Fairvalue-Calculator Fairvalue-Calculator
EN DE

HYTN Innovations Inc (HYTNF) Fair Value & Analysis

Consumer Defensive · US · Market cap $15.6M

Price$0.1623
Fair Value$0.0300
Upside-81.5%
Quality95/100
Evidence: Low Range $0.0200 – $0.0400

Fair value as of: Jun 23, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

HYTN Innovations Inc (HYTNF) currently trades at $0.1623, while our model-based Fair Value estimate is $0.0300 — implying the stock looks roughly 81.5% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

HYTN Innovations Inc. engages in the export and sale of cannabis products in Canada and Australia. The company offers edible cannabis, cannabis beverages, and cannabis flowers. The company is based in Kelowna, Canada.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is HYTN Innovations Inc (HYTNF) undervalued?
As of Jun 23, 2026, our model estimates a fair value of $0.0300 versus a price of $0.1623 — about −82% (overvalued). Model-based estimate, not financial advice.
What is the fair value of HYTNF?
Our 21-model fair value for HYTN Innovations Inc is $0.0300 (as of Jun 23, 2026), built from audited fundamentals. The current price is $0.1623.
What is the quality score of HYTNF?
HYTN Innovations Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.